GORE® SYNECOR Biomaterial is not authorized for use in Canada.

contract-relationship-red

Data Summary

Long-term follow up:

  • 32 months mean (14-53 months range)  
  • Patients: 459
  • Intraperitoneal placement: 76%
    • Bridging repair: 57%
  • Laparoscopic and robotic approaches: 95% 
economic-value-2-red

Quality outcomes

  • Hernia recurrence:
    • 0.9% clinically confirmed hernia recurrence (4/459 patients, mean 32 months) 
      (data on file 2022; W. L. Gore & Associates, Inc; Flagstaff, AZ.)
  • Seroma: 0% (12 months)
  • Surgical site infection (SSI): 2% (12 months)
  • Surgical site occurrence requiring procedural intervention (SSOPI): <3% (24 months)
  • Adhesion formation: 0% (12 months) 
surgery-red

Patient characteristics

  • Mean body mass index (BMI): > 33 kg/m2
    • Obese: 63%
  • Diabetes mellitus: 20%
  • Tobacco users: 9%
    • Current users: 19%
    • Former users: 32%
  • Ventral hernia working group (VHWG) classification
    • Grade 1: 23%
    • Grade 2: 77%
  1. Doerhoff C, Grantham D, Mallico E, Washington R, Linn J. Long-term outcomes following hybrid biomaterial repair of ventral hernias: a multicenter, retrospective study. Presented at the EHS-AHS Joint Congress 2021; October 13-16, 2021; Copenhagen, Denmark. British Journal of Surgery 2021;108(8)Supplement:viii42. PO90.
IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

INDICATIONS FOR USE: The GORE® SYNECOR Intraperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall or thoracic wall soft tissue deficiencies that may require the addition of a nonabsorbable reinforcing or bridging material.

CONTRAINDICATIONS: The GORE® SYNECOR Intraperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects.

INDICATIONS FOR USE: The GORE® SYNECOR Preperitoneal Biomaterial device is intended for use in the repair of hernias and abdominal wall soft tissue deficiencies that may require the addition of a non-absorbable reinforcing or bridging material.  

CONTRAINDICATIONS: The GORE® SYNECOR Preperitoneal Biomaterial is contraindicated for use in reconstruction of cardiovascular defects. 

24GP1095-EN01